AnaptysBio
NASDAQ: ANABSan Diego, US · Founded 2005 · Delaware corporation · 73 employees on LinkedIn · 5 known investors
Find your way into AnaptysBio
AnaptysBio manages the financial collaborations from Jemperli (with GSK) and imsidolimab (with Vanda), operating a virtual model focused on protecting and returning royalty and milestone value to stockholders. It is a publicly traded biotech company running with fewer than ~10 contractors.
Founders & leadership
RH
Robert HoffmaninChief Financial Officer2015–2016
ML
Marco LondeiinChief Development Officer2014–2020
HS
Hamza SuriainPresident & CEO2011–2022
DF
Daniel FagainPresident, CEO, and Director
CM
Christopher MurphyCFO
Board
CG
Carol GallagherBoard director
TA
JT
JS
John SchmidBoard director
NL
Nicholas LydonBoard director
HR
Hollings RentonBoard director
Investors · 5
Reported raises · per SEC filings
Form D private placements$40.8M disclosed across 1 round · 2015
▶$40.8MraisedJul 2015 · 19 investors · BiotechnologyRule 506(b)
▶$40.8MraisedJul 2015 · 19 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert HoffmanExecutive Officer
- Carol GallagherDirector
- Marco LondeiExecutive Officer
- Tiba AynechiDirector
- John SchmidDirector
- Nicholas LydonDirector
- Hamza SuriaExecutive Officer, Director
- Hollings RentonDirector
- James TopperDirector
- Offering amount
- $40.8M
- Amount sold
- $40.8M
- First sale
- Jul 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through AnaptysBio went on to found or lead other companies.
Competitors · 5
by search overlap
Fortis Life Sciences25 shared keywordsFortis Life Sciences develops and manufactures Bethyl-branded ELISA kits and related reagents, buffers, and antibodies for detecting target proteins in research and diagnostic applications. The kits cover human and veterinary targets and are made in the USA using the company's own antibodies.
Eli Lilly25 shared keywordsEli Lilly discovers, develops, manufactures, and markets human pharmaceutical products across cardiometabolic, oncology, immunology, and neuroscience therapeutic areas, selling to healthcare providers and patients in approximately 90 countries through wholesalers, direct sales representatives, and digital platforms.
Bioworld24 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Aro Biotherapeutics24 shared keywordsAro Biotherapeutics develops tissue-targeted genetic medicines using a proprietary protein technology called Centyrins. The company builds a wholly-owned pipeline of Centyrin-based therapeutic candidates and partners with industry to enable tissue-specific targeting of therapeutics across a range of diseases.
Seeking Alpha24 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
Companies competing with AnaptysBio for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
GSK Eyes AnaptysBio (ANAB) Acquisition to Secure Drug Controlfinance.yahoo.com · Aug 2026
AnaptysBio (ANAB) investors back director slate, auditor and equity plan changesstocktitan.net · Aug 2026Frequently asked questions
- What does AnaptysBio do?
- AnaptysBio manages the financial collaborations from Jemperli (with GSK) and imsidolimab (with Vanda), operating a virtual model focused on protecting and returning royalty and milestone value to stockholders. It is a publicly traded biotech company running with fewer than ~10 contractors.
- Who are AnaptysBio's investors?
- AnaptysBio's investors include BioBrit, Frazier Life Sciences, Biotechnology Value Fund, Norwest Venture Partners, Novo Holdings.
- How much funding has AnaptysBio raised?
- AnaptysBio has disclosed $40.8M raised across 1 round.
- Where is AnaptysBio headquartered?
- AnaptysBio is headquartered in San Diego, US.